Cargando…

ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy

Angiopoietin-like 4 (ANGPTL4) is an important regulator of plasma triglyceride (TG) levels and an attractive pharmacological target for lowering plasma lipids and reducing cardiovascular risk. Here, we aimed to study the efficacy and safety of silencing ANGPTL4 in the livers of mice using hepatocyte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Mingjuan, Kutrolli, Elda, Sadewasser, Anne, Michel, Sven, Joibari, Masoumeh Motamedi, Jaschinski, Frank, Olivecrona, Gunilla, Nilsson, Stefan K., Kersten, Sander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270256/ https://www.ncbi.nlm.nih.gov/pubmed/35667416 http://dx.doi.org/10.1016/j.jlr.2022.100237

Ejemplares similares

Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue
por: Kroupa, Olessia, et al.
Publicado: (2012)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
por: Jani, Saumya, et al.
Publicado: (2021)

Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue
por: Ruppert, Philip M.M., et al.
Publicado: (2020)

Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4
por: Landfors, Fredrik, et al.
Publicado: (2022)

ANGPTL3 as therapeutic target
por: Kersten, Sander
Publicado: (2021)

Serum ANGPTL8 and ANGPTL3 as Predictors of Triglyceride Elevation in Adult Women
por: Stefanska, Anna, et al.
Publicado: (2022)

Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery disease
por: Biterova, Ekaterina, et al.
Publicado: (2018)

ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure
por: Dijk, Wieneke, et al.
Publicado: (2015)

Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
por: Kashyap, Abhishek S., et al.
Publicado: (2019)

Volanesorsen, an Antisense Oligonucleotide to Apolipoprotein-CIII, Decreases Triglycerides and Increases Lipoprotein Lipase Activity in Partial Lipodystrophy
por: Lightbourne, Marissa, et al.
Publicado: (2021)

A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells
por: Castanotto, Daniela, et al.
Publicado: (2015)

Hydrogen peroxide-triggered gene silencing in mammalian cells through boronated antisense oligonucleotides
por: Mori, Shohei, et al.
Publicado: (2017)

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis
por: Korobeynikov, Vladislav A., et al.
Publicado: (2022)

Antisense oligonucleotides in neurological disorders
por: Wurster, Claudia D., et al.
Publicado: (2018)

Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017)

Antisense oligonucleotides: A primer
por: Scoles, Daniel R., et al.
Publicado: (2019)

Antisense Oligonucleotides and RNA Interference
por: Kher, Gitanjali, et al.
Publicado: (2011)

ANGPTL4/8 promotes plasmin-mediated cleavage of LPL inhibitors
por: Kersten, Sander
Publicado: (2023)

Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
por: Stein, C. A., et al.
Publicado: (2010)

Boron Clusters as Enhancers of RNase H Activity in the Smart Strategy of Gene Silencing by Antisense Oligonucleotides
por: Kaniowski, Damian, et al.
Publicado: (2022)

A low-carbohydrate high-fat diet decreases lean mass and impairs cardiac function in pair-fed female C57BL/6J mice
por: Nilsson, Jessica, et al.
Publicado: (2016)

Regulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice
por: Spitler, Kathryn M., et al.
Publicado: (2021)

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
por: Gaudet, Daniel, et al.
Publicado: (2020)

Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
por: Lennox, Kim A., et al.
Publicado: (2016)

The use of nano-sized acicular material, sliding friction, and antisense DNA oligonucleotides to silence bacterial genes
por: Mitsudome, Yuya, et al.
Publicado: (2014)

Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against Sporothrix schenckii
por: Batista-Duharte, Alexander, et al.
Publicado: (2021)

Intratracheally administered LNA gapmer antisense oligonucleotides induce robust gene silencing in mouse lung fibroblasts
por: Shin, Minwook, et al.
Publicado: (2022)

Multi-Functionalized Heteroduplex Antisense Oligonucleotides for Targeted Intracellular Delivery and Gene Silencing in HeLa Cells
por: Sousa de Almeida, Mauro, et al.
Publicado: (2022)

Opportunities and challenges for antisense oligonucleotide therapies
por: Kuijper, Elsa C., et al.
Publicado: (2020)

Drug Discovery Perspectives of Antisense Oligonucleotides
por: Kim, Yeonjoon
Publicado: (2023)

In-silico study of antisense oligonucleotide antibiotics
por: Chen, Erica S., et al.
Publicado: (2023)

Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism
por: Kersten, Sander
Publicado: (2021)

Anti-Niemann Pick C1 Single-Stranded Oligonucleotides with Locked Nucleic Acids Potently Reduce Ebola Virus Infection In Vitro
por: Sadewasser, Anne, et al.
Publicado: (2019)

The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
por: Zhang, Ren
Publicado: (2016)

Reduction of Off-Target Effects of Gapmer Antisense Oligonucleotides by Oligonucleotide Extension
por: Yasuhara, Hidenori, et al.
Publicado: (2022)

Silencing of ANGPTL8 Alleviates Insulin Resistance in Trophoblast Cells
por: Bai, Yu, et al.
Publicado: (2021)

Antisense Oligonucleotide-Mediated Silencing of Mitochondrial Fusion and Fission Factors Modulates Mitochondrial Dynamics and Rescues Mitochondrial Dysfunction
por: Garcia, Daniel A., et al.
Publicado: (2022)

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021)

Superior Silencing by 2′,4′-BNA(NC)-Based Short Antisense Oligonucleotides Compared to 2′,4′-BNA/LNA-Based Apolipoprotein B Antisense Inhibitors
por: Yamamoto, Tsuyoshi, et al.
Publicado: (2012)

Improved targeting of miRNA with antisense oligonucleotides
por: Davis, Scott, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_gd8182n6rkkv4amm3pm4diolb8